Inhibition of MicroRNA-17 Improves Lung and Heart Function in Experimental Pulmonary Hypertension
Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Stefanie Dimmeler(Goethe University Frankfurt), Baktybek Kojonazarov(Cardio-Pulmonary Institute), Carmen Doebele, Angelika Bonauer, Norbert Weißmann(Cardio-Pulmonary Institute), Rajkumar Savai(Goethe University Frankfurt), Andreas M. Zeiher(Goethe University Frankfurt), Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Ariane Fischer(Goethe University Frankfurt), Bhola K. Dahal, Werner Seeger(Justus-Liebig-Universität Gießen)
American Journal of Respiratory and Critical Care Medicine
December 9, 2011
Cited by 229
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k